Singapore-based health tech startup AIGP Health has received Class A approval from the Health Sciences Authority (HSA) for its AI-powered clinical assistant — becoming the first company in the country to secure this designation.
The approval paves the way for the clinician-founded firm to expand its platform to general practice clinics and telehealth providers in Singapore, with overseas rollout planned later.
Built by practising doctors, the platform uses natural language processing to help healthcare professionals with real-time note-taking, patient data summaries, and consultation prompts. It is classified as low-risk software, with all medical decisions remaining under physician control, in line with HSA rules.
Dr Prateet Narula, co-founder of AIGP Health, using the Anzu clinical assistant during a live consultation.
“This milestone reaffirms our belief that technology should support, not replace, the human touch in healthcare,” said Dr Anindita Santosa, co-founder and CEO of AIGP Health.
With regulatory clearance, the startup can now move beyond pilots into wider deployment, aiming to reduce administrative tasks for doctors while improving continuity of care for patients.
Singapore’s regulators have emphasised that AI in healthcare must augment, not replace, clinical judgement under its digital health framework.
